2018
DOI: 10.1016/j.compbiolchem.2018.04.003
|View full text |Cite
|
Sign up to set email alerts
|

In-vitro evaluation and in-silico studies applied on newly synthesized amide derivatives of N-phthaloylglycine as Butyrylcholinesterase (BChE) inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 32 publications
0
3
0
Order By: Relevance
“…According to S. Bhadra et al, (2016) asiatic acid, a triterpenoid component of CA, was found to have an inhibitory effect against the AChE enzyme [ 9 ]. N. Omar et al, (2019) reported that asiatic acid that was present in CA could cross the blood–brain barrier (BBB) and maintained in the tight junction of the BBB [ 24 ]. Furthermore, it has been reported that the combination of asiatic acid and madecassic acid could induce neuronal differentiation and neurofilament [ 39 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…According to S. Bhadra et al, (2016) asiatic acid, a triterpenoid component of CA, was found to have an inhibitory effect against the AChE enzyme [ 9 ]. N. Omar et al, (2019) reported that asiatic acid that was present in CA could cross the blood–brain barrier (BBB) and maintained in the tight junction of the BBB [ 24 ]. Furthermore, it has been reported that the combination of asiatic acid and madecassic acid could induce neuronal differentiation and neurofilament [ 39 ].…”
Section: Resultsmentioning
confidence: 99%
“…Molecular docking is a tool in computer aided drug designing (CADD) which is used to study the binding interaction between the potential inhibitors, known as ligands, and targeted enzymes [24]. The X-ray crystal structures of AChE from various species can be found in the protein data bank (PDB) [25].…”
Section: Introductionmentioning
confidence: 99%
“…Benzothiazole (fragment A) and isoquinoline (fragment C) are connected by an amide bond (fragment B) because amide compounds are used to treat illnesses of the central nervous system, such as anxiety, schizophrenia, epilepsy and depression, and have antioxidant pharmacological activity [52][53][54][55]. The most relevant parameters of the newly created MTDLs included physicochemical features of the compounds in connection to their drug-likeness and success in the drug development process.…”
Section: Introductionmentioning
confidence: 99%